Preclinical Imaging

You are here

Preclinical Imaging

 

Recent Headlines

Study: New peptide probes could help detect disease faster

A new advancement in real-time visualization of body tissues using molecular imaging probes could significantly increase early detection and treatment capabilities of cancer and other diseases, according to results of a study published online in Nature Communications.

PET solves the riddle of drug resistance in tuberculosis research

Dual human and preclinical PET scans shine a light on treatments for tuberculosis (TB) and aid in drug discovery and selection, according to researchers at the University of Pittsburgh School of Medicine. University officials announced on Dec. 3 the results of a pivotal study noting that quantitative PET was earmarked for future clinical trials.

Hunger hormone could signal treatments for Parkinson’s

As Americans anticipate their Thanksgiving dinners, the gnawing sensation of hunger prepares them to eat perhaps too much turkey or pumpkin pie. The same hormone that produces that sensation of hunger could be the secret to a new therapy protecting Parkinson’s patients from disease-related cell death, according to research presented Nov. 16 during the Society of Neuroscience’s annual meeting in Chicago.

Protea’s gross revenues up 190% in third quarter

Protea Biosciences, a biomedical company based in Morgantown, W. Va, announced yesterday that third quarter financial results amounted to $517,569, the highest revenue on record for the company. However net losses are still steep at more than $4.6 million for the third quarter.

WMIS highlights from World Nuclear Medicine and Molecular Imaging Week

Saturday marked the final day of the 2014 Nuclear Medicine and Molecular Imaging Week and, to celebrate, the World Molecular Imaging Society (WMIS) announced highlights of the recent 7th World Molecular Imaging Congress held in Seoul, Korea.

WMIC: Looking ahead to 2015

The 2014 World Molecular Imaging Congress (WMIC) put a spotlight on the basic science and translation of molecular imaging at the World Trade Center in Seoul, South Korea, from Sept. 17-20. Molecular Imaging caught up with three central figures of the 2015 WMIC to find out more about emerging trends in molecular imaging and ways in which the WMIS operates to aid translation of preclinical research to first-in-human trials.

WMIC 2014: Angiogenesis, nanotheranostics and stem cell imaging

This year’s World Molecular Imaging Congress (WMIC), the Annual Meeting of the World Molecular Imaging Society (WMIS), brought the most cutting edge research and technology in preclinical research and molecular imaging technology to the World Trade Center in Seoul, Korea, from Sept. 17-20.

FDG PET finds signs of muscle denervation

A high uptake of FDG could signal glucose hypermetabolism in muscle, making FDG PET a novel addition to more conventional methods of detecting denervation, according to a study published Aug. 7 in the Journal of Nuclear Medicine.

Bruker acquires Vutara optical imaging

Bruker Corporation of Billerica, Mass., has announced that the provider of instrumentation for biomedical research has acquired Vutara Incorporated, producers of high-speed and resolution 3D fluorescence microscopy.

Genes, neuroimaging suggest mothers instill their distress in their young

Lasting memories of trauma and aversion can be passed on from mother-to-baby in a kind of biochemical generational stamp, researchers from the University of Michigan announced yesterday.

Pages